Join a community of interest
Standards and specifications to electronically share health information consistently, safely and reliably
Support for digital health implementations
Resources and enablers to accelerate clinical interoperability
What's going on in clinical interoperability and digital health
What this site is about, future plans and how to reach us
Share this page:
|
Welcome,
Guest
|
|
Regardless of the LOINC code that is currently being used for SARS CoV-2, LOINC is strongly recommending that details about the specimen and the test kit along with the primary result be reported.
Specimen details would ideally be reported using the HL7 SPM segment if using v2.5.1 or higher, OBR-15 if using v2.3.x, or the FHIR Specimen resource. If none of these are supported, specimen details can be sent as a separate observation result using LOINC 66746-9 Specimen type. The test kit name and/or unique identifier would ideally be reported in OBX-17 and OBX-18, respectively. If this is not an option, test kit details can be sent as separate observation results using LOINC 67099-2 Vendor device name and/or 74711-3 Unique device identifier. If there are any questions, please let us know and we can liaise with LOINC team at RI. |
|
Last Edit: 5 years 1 month ago by lmonico.
The administrator has disabled public write access.
|
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.
Print
Email